CureVac files for U.S. IPO: Reuters
German biotech CureVac, which is developing a coronavirus vaccine, has filed for a U.S. IPO, reported Reuters.
27 July 2020•1 min read
German biotech CureVac, which is developing a coronavirus vaccine, has filed for a U.S. IPO, reported Reuters.
EQT-backed Sagility acquires clinical documentation and coding firm Chirok Health
23 October 2026 · 1 min read
Blue Sea Capital-backed One Physics adds two West Coast medical physics firms
23 October 2026 · 1 min read
AEA Investors-backed American Oncology Network inks $2.4bn sale to Cencora
23 October 2026 · 2 mins read
Warburg Pincus-backed Appasamy acquires German ophthalmic surgery firm Ruck
23 October 2026 · 1 min read
New Harbor Capital’s LGM Pharma acquires contract lab Sannova Analytical
23 October 2026 · 2 mins read
Amulet-backed TFP Fertility acquires Manchester Fertility Group in UK add-on
23 October 2026 · 1 min read
Rubicon Technology Partners’ Procede Software acquires dealer software firm RIMSS
23 October 2026 · 2 mins read
